Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT03837574
Recruiting Observational

French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator

NCT03837574 · tracked via the Priya Life Science France tracker
Sponsor
Paris Sudden Death Expertise Center
Phase
Observational
Started
2010-12-01
Last updated
2019-02-12

Condition(s) studied

Tetralogy of FallotImplantable Defibrillator UserCongenital Heart DiseaseSudden Cardiac DeathVentricular Arrythmia

Study summary

National french registry of patients with tetralogy of Fallot and implantable cardioverter defibrillator.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * tetralogy of Fallot * implantable cardioverter defibrillator Exclusion Criteria: * age \< 18 years

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Paris Sudden Death Expertise Center Paris France Recruiting

More Paris Sudden Death Expertise Center trials in France

French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR Recruiting
French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV Recruiting

Other trials for the same condition

Neuro-cardiac Rehabilitation in Youth With Congenital Heart Disease (QUALINEUROREHAB) Recruiting
Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction Starting soon
French Observatory of Congenital Ventricular Septal Defect With Pulmonary Overload Active, not recruiting
International Multicenter Outcomes of Transcatheter Pulmonary Flow Restrictors in Congenital and Acquired Heart Disease Enrolling by invitation
OPTImal Treatment of Sinus VENOSUS Defect Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03837574 on ClinicalTrials.gov ↗ ← All trials in France